Endothelin alters the reactivity of vasa vasorum: Mechanisms and implications for conduit vessel physiology and pathophysiology

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1229-1234

  Scotland, Ramona ^a   Vallance, Patrick ^a   Ahluwalia, Amrita ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

BQ123; BQ788; Endothelin; Sarafotoxin; Vasa vasorum

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NICKEL; NORADRENALIN; SARAFOTOXIN; THROMBOXANE A2;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; GREAT BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; SWINE; THORACIC AORTA; VASA VASORUM; VASOCONSTRICTION;

EID: 0032715455     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702930     Document Type: Article

References (36)

1. AWANE-IGATA, Y., IKEDA, S. & WATANABE, T. (1997). Inhibitory effects of TAK-044 on endothelin induced vasoconstriction in various canine arteries and porcine coronary arteries: a comparison with selective ETA and ETB receptor antagonists. Br. J. Pharmacol., 120, 516-522.
2. BACON, C.R., CAREY, N.R. & DAVENPORT, A.P. (1996). Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ. Res., 79, 794-801.
3. BAX, W.A. & SAXENA, P.R. (1994). The current endothelin receptor classification: time for reconsideration?. Trends Pharmacol. Sci., 15, 379-386.
4. BODI, I., BISHOPRIC, N.H., DISCHER, D.J., WU, X. & WEBSTER, K.A. (1995). Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxia. Cardiovasc. Res., 30, 975-984.
5. BROOKS, D.P., JORKASKY, D.K., FREED, M.I. & OHLSTEIN, E.H. (1998). Pathophysiological role of endothelin and potential therapeutic targets for receptor antagonists. In: Highsmith, R.F. (ed.). Endothelin: Molecular Biology, Physiology, and Pathophysiology, pp. 223-268. Totowa: NJ.
6. DASHWOOD, M.R., BARKER, S.G.E., MUDDLE, J.R., YACOUB, M.H. & MARTIN, J.F. (1993). 125-ET-1 binding to the vasa vasorum and regions of neovasclarization in human and porcine blood vessels: a possible role for endothelin in intimal hyperplasia and atherosclerosis. J. Cardiovasc. Pharm., 8, S343-S347.
7. DECKER, E.R. & BROCK, T.A. (1998). Endothelin receptor-signaling mechanisms in vascular smooth muscle. In: Highsmith R.F., (ed). Endothelin: Molecular Biology, Physiology, and Pathophysiology, pp. 93-119. Totowa: NJ.
8. GROTE, J., SIEGEL, G., ZIMMER, K. & ADLER, A. (1988). The influence of oxygen tension on membrane potential and tone of canine carotid artery smooth muscle. Adv. Exp. Med. Biol., 222, 481-487.
9. IHARA, M., ISHIKAWA, K., FUKURODA, T., SAEKI, T., FUNABASHI, K., FUKAMI, T., SUDA, H. & YANO, M. (1992a). In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J. Cardiovasc. Pharmacol., 20, (Suppl 12), S11-S14.
10. IHARA, M., NOGUCHI, K., SAEKI, T., FUKURODA, T., TSUCHIDA, S., KIMURA, S., FUKAMI, T., ISHIKAWA, K., NISHIKIBE, M. & YANO, M. (1992b). Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci., 50, 247-255.
11. ISHIKAWA, K., IHARA, M., NOGUCHI, K., MASE, T., MINO, N., SAEKI, T., FUKURODA, T., FUKAMI, T., OZAKI, S. & NAGASE, T. (1994). Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U. S. A., 91, 4892-4896.
12. MARSEN, T.A., SIMONSON, M.S. & DUNN, M.J. (1995). Thrombin induces the preproendothelinl gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ. Res., 76, 987-995.
13. MARTIN, J.F., BOOTH, R.F.G. & MONCADA, S. (1991). Arterial wall hypoxia following thrombosis of the vasa vasorum is an initial lesion in atherosclerosis. Eur. J. Clin. Invest., 21, 355-359.
14. MCLEAN, P.G. & COUPAR, I.M. (1996). Characterisation of a postjunctional 5-ht7-like and a prejunctional 5-HT3 receptor mediating contraction of rat isolated jejunum. Eur. J. Pharmacol., 312, 215-225.
15. MERRITT, J.E., ARMSTRONG, W.P., BENHAM, C.D., HALLAM, T.J., JACOB, R., JAXA-CHAMIEC, A., LEIGH, B.K., MCCARTHY, S.A., MOORES, K.E. & RINK, T.J. (1990). SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J., 271, 515-522.
16. MICKLEY, E.J., GRAY, G.A. & WEBB, D.J. (1997). Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries. Br. J. Pharmacol., 120, 1376-1382.
17. MULVANY, M.J. & HALPERN, W. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-26.
18. NAKATA, Y. & SHIONOYA, S. (1966). Vascular lesions due to obstruction of the vasa vasorum. Nature, 212, 1258-1259.
19. OKATANI, Y., TANIGUCHI, K. & SAGARA, Y. (1995). Amplifying effect of endothelin-1 on serotonin-induced vasoconstriction of human umbilical artery. Am. J. Obstet. Gynecol., 172, 1240-1245.
20. PAPE, D., BEUCHARD, J., GUILLO, P., ALLAIN, H. & BELLISSANT, E. (1997). Hypoxic contractile response in isolated rat thoracic aorta: role of endothelium, extracellular calcium and endothelin. Fundam. Clin. Pharmacol., 11, 121-126.
21. PIERRE, L.N. & DAVENPORT, A.P. (1998). Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Br. J. Pharmacol., 124, 499-506.
22. RAKUGI, H., TABUCHI, Y., NAKAMARU, M., NAGANO, M., HIGASHIMORI, K., MIKAMI, H. & OGIHARA, T. (1990). Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxia. Biochem. Biophys. Res. Comm., 169, 973-977.
23. SARSERO, D., FUJIWARA, T., MOLENAAR, P. & ANGUS, J.A. (1998). Human vascular to cardiac tissue selectivity of L-and T-type calcium channel antagonists. Br. J. Pharmacol., 125, 109-119.
24. SCOTLAND, R., VALLANCE, P. & AHLUWALIA, A. (1999). On the regulation of tone in vasa vasorum. Cardiovasc. Res., 41, 237-245.
25. SEIDLER, N.W., JONA, I., VEGH, M. & MARTONOSI, A. (1989). Cyclopiazonic acid is a specific inhibitor of the Ca2 + -ATPase of sarcoplasmic reticulum. J. Biol. Chem., 264, 17816-17823.
26. SHETTY, S.S. & DELGRANDE, D. (1994). Inhibition by nickel of endothelin-1-induced tension and associated 45Ca movements in rabbit aorta. J. Pharmacol. Exp. Ther., 271, 1223-1227.
27. SOMLYO, A.P. & SOMLYO, A.V. (1994). Signal transduction and regulation in smooth muscle. Nature, 372, 231-236.
28. STEFANADIS, C.I., KARAYANNACOS, P.E., BOUDOUAS, H.K., STRATOS, C.G., VLACHOPOULOS, C.V., DONTAS, I.A. & TOUTOUZAS, P.K. (1993). Medial necrosis and acute alterations in aortic distensibility following removal of the vasa vasorum of canine ascending aorta. Cardiovasc. Res., 27, 951-956.
29. STUPECKY, G.L., MURRAY, D.L. & PURDY, R.E. (1986). Vasoconstrictor threshold synergism and potentiation in the rabbit isolated thoracic aorta. J. Pharmacol. Exp. Ther., 238, 802-808.
30. TABUCHI, Y., NAKAMARU, M., RAKUGI, H., NAGANO, M. & OGIHARA, T. (1989). Endothelin enhances adrenergic vasoconstriction in prefused rat mesenteric arteries. Biochem. Biophys. Res. Comm., 159, 1304-1308.
31. TABUCHI, Y., SHI, S., MIKAMI, H. & OGIHARA, T. (1991). Endothelin modulates L-N-Nitroarginine-induced enhancement of vasoconstriction evoked by norepinephrine. J. Cardiovasc. Pharm., 17, S203-S205.
32. WILLIAMS JR., D.L., JONES, K.L., PETTIBONE, D.J., LIS, E.V. & CLINESCHMIDT, B.V. (1991). Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun., 175, 556-561.
33. WILLIAMS, J.K. & HEISTAD, D.D. (1996). Structure and function of vasa vasorum. Trends Cardiovasc. Med., 6, 53-57.
34. YANG, Z.H., RICHARD, V., VON SEGESSER, L., BAUER, E., STULZ, P., TURINA, M. & LUSCHER, T.F. (1990). Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm. Circulation, 82, 188-195.
35. YUAN, X., GOLDMAN, W.F., TOD, M.L., RUBIN, L.J. & BLAUSTEIN, M.P. (1993). Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes. Am. J. Physiol., 264, L116-L123.
36. ZHANG, J., OKAMURA, T. & TODA, N. (1996). Pre-and postjunctional modulation by endothelin-1 of the adrenergic neurogenic response in canine mesenteric arteries. Eur. J. Pharmacol., 311, 169-176.